Maykin Ho Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Maykin Ho.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Maykin Ho. Maykin Ho is Director in PAREXEL INTERNATIONAL CORP ($PRXL) and Director in BIOMARIN PHARMACEUTICAL INC ($BMRN) and Director in FIBROGEN INC ($FGEN) and Director in AGIOS PHARMACEUTICALS INC ($AGIO).
Latest Insider Trading Transactions of Maykin Ho
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AGIO, BMRN, FGEN, PRXL
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 19 2021 | BMRN | BIOMARIN PHARMACEU ... | Ho Maykin | Director | Grant | A | 0.00 | 2,350 | 0 | 2,350 | 0 to 2.4 K |
| Jun 08 2020 | FGEN | FIBROGEN INC | Ho Maykin | Director | Option Exercise | A | 32.69 | 7,800 | 254,982 | 7,800 | |
| Jun 08 2020 | FGEN | FIBROGEN INC | Ho Maykin | Director | Grant | A | 0.00 | 4,700 | 0 | 11,255 | 6.6 K to 11.3 K (+71.70 %) |
| Jun 01 2020 | AGIO | AGIOS PHARMACEUTIC ... | Ho Maykin | Director | Option Exercise | M | 0.00 | 1,878 | 0 | 0 | |
| Jun 01 2020 | AGIO | AGIOS PHARMACEUTIC ... | Ho Maykin | Director | Option Exercise | A | 0.00 | 1,686 | 0 | 1,686 | |
| Jun 01 2020 | AGIO | AGIOS PHARMACEUTIC ... | Ho Maykin | Director | Option Exercise | A | 53.35 | 8,096 | 431,922 | 8,096 | |
| Jun 01 2020 | AGIO | AGIOS PHARMACEUTIC ... | Ho Maykin | Director | Buy | M | 0.00 | 1,878 | 0 | 3,278 | 1.4 K to 3.3 K (+134.14 %) |
| Jun 07 2019 | FGEN | FIBROGEN INC | Ho Maykin | Director | Option Exercise | A | 39.03 | 7,800 | 304,434 | 7,800 | |
| Jun 07 2019 | FGEN | FIBROGEN INC | Ho Maykin | Director | Grant | A | 0.00 | 4,700 | 0 | 6,555 | 1.9 K to 6.6 K (+253.37 %) |
| May 31 2019 | AGIO | AGIOS PHARMACEUTIC ... | Ho Maykin | Director | Option Exercise | M | 0.00 | 1,400 | 0 | 0 | |
| May 31 2019 | AGIO | AGIOS PHARMACEUTIC ... | Ho Maykin | Director | Option Exercise | A | 0.00 | 1,878 | 0 | 1,878 | |
| May 31 2019 | AGIO | AGIOS PHARMACEUTIC ... | Ho Maykin | Director | Option Exercise | A | 47.91 | 8,919 | 427,309 | 8,919 | |
| May 31 2019 | AGIO | AGIOS PHARMACEUTIC ... | Ho Maykin | Director | Buy | M | 0.00 | 1,400 | 0 | 1,400 | 0 to 1.4 K |
| Dec 07 2018 | FGEN | FIBROGEN INC | Ho Maykin | Director | Option Exercise | A | 41.34 | 3,008 | 124,351 | 3,008 | |
| Dec 07 2018 | FGEN | FIBROGEN INC | Ho Maykin | Director | Option Exercise | A | 41.34 | 10,400 | 429,936 | 10,400 | |
| Dec 07 2018 | FGEN | FIBROGEN INC | Ho Maykin | Director | Grant | A | 0.00 | 1,855 | 0 | 1,855 | 0 to 1.9 K |
| Oct 04 2017 | PRXL | PAREXEL INTERNATIO ... | Ho Maykin | Director | Sell | D | 0.00 | 6,612 | 0 | 0 | 6.6 K to 0 (-100.00 %) |
| Sep 11 2017 | PRXL | PAREXEL INTERNATIO ... | Ho Maykin | Director | Grant | A | 0.00 | 1,823 | 0 | 6,612 | 4.8 K to 6.6 K (+38.07 %) |
| Jun 15 2017 | AGIO | AGIOS PHARMACEUTIC ... | Ho Maykin | Director | Option Exercise | A | 50.73 | 8,000 | 405,840 | 8,000 | |
| Sep 16 2016 | PRXL | PAREXEL INTERNATIO ... | Ho Maykin | Director | Grant | A | 0.00 | 2,369 | 0 | 4,789 | 2.4 K to 4.8 K (+97.89 %) |
| Jun 23 2016 | AGIO | AGIOS PHARMACEUTIC ... | Ho Maykin | Director | Option Exercise | A | 47.33 | 8,000 | 378,640 | 29,250 | |
| Sep 11 2015 | PRXL | PAREXEL INTERNATIO ... | Ho Maykin | Director | Grant | A | 0.00 | 2,420 | 0 | 2,420 | 0 to 2.4 K |
| Jun 26 2015 | AGIO | AGIOS PHARMACEUTIC ... | Ho Maykin | Director | Option Exercise | A | 103.63 | 21,250 | 2,202,138 | 21,250 |
Page: 1